LYNSEY SULLIVAN: Open Payments
NPI 1417492539 · HOUSTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152 in 7 payments from 5 companies in 2025. Trend: 2023 $31 · 2024 $211 · 2025 $152
Food & beverage: $152
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Insulet Corporation | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $17 |
Products named: Ohtuvayre, Omnipod, REXULTI, BREZTRI, MOUNJARO, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
